KLAS 2026 RCM Suites Report: Deep Single-Vendor Adopters Collect More

Bypaulgruensfelder
KLAS Research / HIT Consultant July 22, 2026
Read Full Article →
AI-Generated Summary

Healthcare organizations that run three or more revenue cycle modules from a single vendor — ‘deep adopters’ — report better cash collections and a lower cost to collect than those stitching together point solutions, according to KLAS Research’s 2026 Revenue Cycle Management Suites report. Waystar earned the highest overall grade, an ‘A,’ on the strength of strategic partnership, a cohesive UI across acquired modules, transparent bundled pricing, and high adoption of AI-generated appeals. The top drivers for going all-in with one RCM vendor were vendor consolidation (57%) and building a stronger strategic partnership (57%), followed by pricing (43%) and expanded functionality (41%). KLAS cautioned that no single vendor yet offers a fully mature, end-to-end platform without functional trade-offs.

Why It Matters

For CFOs and revenue cycle leaders weighing best-of-breed versus single-vendor consolidation, the data suggests deep integration can lift net collections and cut administrative overhead — but the ‘one throat to choke’ bet still carries functionality gaps worth diligencing before signing.

revenue cycle management RCM vendor consolidation KLAS research cost to collect denials automation cash collections single-vendor strategy

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Do healthcare organizations collect more when they consolidate RCM modules with one vendor?

KLAS’s 2026 RCM Suites report found that ‘deep adopters’ — organizations using three or more distinct RCM modules from a single vendor — consistently report better cash collections and a lower cost to collect. Streamlined workflows and stronger automation across integrated modules reduce the administrative overhead that fragmented point solutions create.

Which RCM vendor scored highest in the KLAS 2026 Revenue Cycle Management Suites report?

Waystar earned the highest overall grade in the report, an ‘A.’ KLAS attributed the rating to strong strategic partnership, a cohesive user interface across acquired modules, bundled pricing that reduces ‘nickel-and-diming,’ and high adoption of AI-generated appeals.

What are the main reasons health systems consolidate revenue cycle work with a single vendor?

The top primary drivers were vendor consolidation and building a stronger strategic partnership, each cited by 57% of respondents, followed by pricing (43%) and expanded functionality (41%). KLAS noted, however, that no single vendor yet delivers a fully mature end-to-end platform without functional trade-offs.

Similar Posts

  • Hospital Mergers as a Lifeline: What Actually Creates Value

    Bypaulgruensfelder

    Hospital mergers are increasingly a survival move rather than a growth play, as roughly $1 trillion in Medicaid cuts under the One Big Beautiful Bill Act and ACA changes squeeze margins and raise uncompensated care. Independent and rural hospitals that lack capital for technology and service expansion are seeking larger partners, but stricter state regulatory reviews now threaten deal timelines — Oregon’s Santiam Hospital warned it could become insolvent by August 1 without an expedited merger. Optum Advisory’s Morgan Haines stresses that “the merger itself is never the value”; stabilization comes from post-close investments in technology, service-line redesign, operational improvements, and community partnerships. Leaders are urged to prioritize “speed-to-value.”

  • Why AI ROI Stalls: The Case for Disciplined Decisions

    Bypaulgruensfelder

    AI initiatives often underdeliver because organizations never define which decisions AI should actually improve — a fixable focus problem, not a technology gap. Summit Partners’ Sharon Lin argues that generative AI has lowered the cost of analysis so dramatically that many teams now face “analysis paralysis at scale,” producing endless dashboards and scenarios while struggling to act. She warns against automating away interpretive, relational work — consultative sales, creative brainstorming, customer insight — where friction itself carries signal. The limiting factor in AI-enabled organizations is rarely access to insight or technology; it is the discipline to identify which decisions AI can genuinely improve and the willingness to protect space for human judgment.

  • Healthcare Payment Models Can’t Reimburse Clinical AI Yet — Here’s the Fix Being Built

    Bypaulgruensfelder

    Today’s healthcare payment models — fee-for-service, pay-for-performance, and capitation — cannot properly reimburse providers for clinical AI, according to a new Peterson Health Technology Institute report drawn from spring 2026 convenings of health system, health plan, technology, investment, academic, and federal leaders. Because autonomous AI decouples value from clinician time, existing coverage rules and incentives fail to support the workflow changes adoption requires, and value-based providers struggle to attribute savings to a specific tool. The group proposed three design principles: pay only when AI demonstrably improves outcomes, cost, or access; price to clinical or economic value with safeguards like price ratcheting; and set adoption-stage rates that decline as evidence and scale grow. The AMA is developing CPT codes for autonomous clinical AI to build the billing infrastructure.

  • 2026 Medicare Reimbursement Changes: What the Conversion Factor Update Really Means

    Bypaulgruensfelder

    Medicare reimbursement remains below the cost of delivering care for 80% of medical groups in 2026, according to an MGMA Stat poll of 166 respondents. CMS set the 2026 Physician Fee Schedule conversion factor at $33.57 for Advanced APM participants and $33.40 for non-participants — increases of 3.77% and 3.26% respectively after years of flat or negative updates. A new -2.5% efficiency adjustment on work RVUs for non-time-based services may offset gains at the service-line level. Telehealth flexibilities are extended through December 2027. Medicare Advantage denial strain from prior authorization and downcoding compounds the squeeze, with operating costs per FTE physician rising 63% from 2013 to 2022 while the conversion factor grew just 1.7%.

  • DSO Deal Roundup: July 2026 Acquisitions, De Novos, and Platform Moves

    Bypaulgruensfelder

    Dental consolidation stayed active in July 2026, with Group Dentistry Now tracking a full slate of DSO and emerging-group transactions. Guardian Dentistry Partners agreed to a strategic majority acquisition of Select Dental Management, adding 38 locations across eight states and Washington, D.C. PDS Health opened 10 de novo practices, pushing its network past 1,100 offices in 24 states. Lone Peak Dental Group acquired 11 pediatric and orthodontic locations across Georgia and South Carolina, while Cherry Tree Dental (nearly 30 offices, ~80,000 patients) added Owens Family Dentistry in Wisconsin. TUSK Practice Sales advised Bowers Orthodontic Specialists on its sale to EPIC4 Specialty Partners. The activity signals continued platform expansion through both M&A and de novo growth.

  • Kaltroco Acquires Smile America, the Largest U.S. School-Based Dental Program

    Bypaulgruensfelder

    Family-owned investment firm Kaltroco has acquired Smile America Partners, the largest school-based mobile dental program in the U.S., from Beach Point Capital Management in a deal announced July 13, 2026. Founded in 1997, Smile America delivers portable dental care and served more than 370,000 children across 8,000-plus schools in 20 states in 2025, generating roughly $20 million in EBITDA on about $100 million in revenue. Beach Point took majority ownership in January 2023 after first partnering with the company in December 2020. Kaltroco, a Jersey-based family office focused on long-term healthcare holdings, plans to fund continued expansion of children’s dental access. Houlihan Lokey and DLA Piper advised Kaltroco.